Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRAMPAS trial of perampanel for prevention of early postoperative seizures after craniotomy for supratentorial brain tumor
jRCTs041230117Not yet recruiting
- Start
- Dec 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in brain neoplasm comparing Perampanel with Observation (2 arms). Primary endpoint: Incidence rate of seizures within 28 days after surgery. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
perampanel
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on jRCTs041230117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041230117.